Skip to main content

Table 2 Assessment schedule of primary and secondary outcomes

From: Web-based cognitive behavioral relapse prevention program with tailored feedback for people with methamphetamine and other drug use problems: protocol for a multicenter randomized controlled trial in Japan

Outcome

Measurement

Baseline (T1)

2-month follow-up (T2)

5-month follow-up (T3)

8-month follow-up (T4)

Primary outcome

     

1

Relapse risk

SRRS

x

x

x

x

2

Longest consecutive duration of abstinence

Longest duration of consecutive abstinent days during the intervention #

 

x

  

Secondary outcome

     

1

Motivation to change

SOCRATES

x

x

x

x

2

Self-efficacy for handling drug use and craving

Self-efficacy Scale for Drug Dependence

x

x

x

x

3

Percentages of abstinent days

Abstinent days in the past 28 or 56 days #

x

x

x

x

4

Differences in change of abstinent days

Summed abstinent days in the past 28 days #

x

x

x

x

5

Health related quality of life

WHOQOL26

x

x

x

x

6

Sense of coherence

3-item sense of coherence scale

x

x

x

x

7

Cost of alcohol and drug

Self-reported cost of drugs or alcohol in the last month (yen)

x

x

x

x

8

Treatment retention

Yes or no

x

x

x

x

9

Self-help group use

Yes or no

x

x

x

x

10

Psychiatric medical cost

Self-reported medical use in the past six months

x

  

x

Feasibility and usability outcome

    

1

Program completion

Number of completed weeks

 

x

  

2

Satisfaction

CSQ-8

 

x

  

3

Usability and usefulness

Original questionnaire

 

x

  
  1. SRRS Stimulant Relapse Risk Scale, SOCRATES-8D Stage of Change Readiness and Treatment Eagerness Scale-8 version for drug use, CSQ-8, 8-item Client Satisfaction Questionnaire
  2. #: Self-reported drug use or abstinence assessed by web-based self-monitoring calendar or the Timeline Follow-back method